SparingVision Raises €75 Million Series B lead by Jeito and UPMC. Participated 4BIO, Bpifrance, RD fund and Ysios
15/09/2022 Press release SPARINGVISION RAISES €75 MILLION SERIES B TO CONTINUE BUILDING WORLD LEADING PORFOLIO OF GENOMICS FOR OCULAR DISEASES. SparingVision (“the Company”), a genomic medicine company developing vision-saving treatments for ocular diseases, today announces that it has raised €75 million in a Series B financing. The round was co-led by Jeito Capital (“Jeito”) and…